|
Mar 14
|
JAZZ or ILMN: Which Is the Better Value Stock Right Now?
|
|
Mar 14
|
Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?
|
|
Mar 14
|
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
|
|
Mar 12
|
BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant
|
|
Mar 12
|
Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day
|
|
Mar 12
|
Bull of the Day: Jazz Pharmaceuticals (JAZZ)
|
|
Mar 10
|
4 Discounted PEG Stocks Offering the Best Returns to Value Investors
|
|
Mar 9
|
Why Chimerix, Inc. (CMRX) Soared Last Week
|
|
Mar 3
|
Jazz Pharmaceuticals plc (JAZZ): Among the Cash-Rich Mid Cap Stocks to Buy Now
|
|
Mar 3
|
Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy?
|
|
Mar 3
|
Wall Street Analysts See a 29.63% Upside in Jazz (JAZZ): Can the Stock Really Move This High?
|
|
Mar 3
|
4 Stocks Trading Near 52-Week High With More Upside Potential
|
|
Feb 28
|
Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy?
|
|
Feb 28
|
International Markets and Jazz (JAZZ): A Deep Dive for Investors
|
|
Feb 28
|
Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
|
|
Feb 26
|
Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term
|
|
Feb 26
|
Despite the downward trend in earnings at Jazz Pharmaceuticals (NASDAQ:JAZZ) the stock advances 3.2%, bringing five-year gains to 21%
|
|
Feb 26
|
Jazz Pharmaceuticals PLC (JAZZ) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...
|
|
Feb 25
|
Compared to Estimates, Jazz (JAZZ) Q4 Earnings: A Look at Key Metrics
|
|
Feb 25
|
Jazz Pharmaceuticals (JAZZ) Tops Q4 Earnings and Revenue Estimates
|